Market Overview:
The global TCR therapy market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in TCR therapy, and rising funding for research on TCR therapy. The global TCR therapy market is segmented by type into transduction of chimeric antigen receptor (CAR) and transduction of T-cell receptor (TCR) α/B heterodimer. The CAR segment is expected to grow at a higher CAGR than the other segments during the forecast period. This can be attributed to the increasing use of CAR-T cells for cancer treatment and rising investment in research on CAR-T cells. The global TCR therapy market is also segmented by application into hospitals, clinics & ambulatory centers, cancer research institutes, and others.
Product Definition:
TCR therapy is a type of immunotherapy that uses T cells to fight cancer. TCR therapy is important because it can help the body's natural defenses fight cancer.
Transduction of Chimeric Antigen Receptor:
Transduction of chimeric antigen receptor (TCR) therapy is a treatment method for patients suffering from chronic myeloid leukemia or acute lymphoblastic leukemia. TCRs are a type of cell-based immunotherapy used to treat cancerous cells. The main aim of this therapy is to stimulate the immune system to act against the cancerous cells, by grafting an artificial TCR onto patient’s own immune cells which recognize and attack the tumor cell.
Transduction of TCR α/B Heterodimer:
TCR-α/B is a newly identified autoantibody that binds to the TCR complex and causes an immune response. The binding of this antibody leads to the activation of complement, coagulation, and inflammation pathways resulting in tissue damage. This pathway is involved in autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, psoriasis among others.
Application Insights:
The others segment held the largest share of the global TCR therapy market in 2017. This segment includes research institutes and other non-clinical facilities. The presence of a large number of players engaged in R&D for developing new products is expected to boost industry growth over the forecast period.
The hospital segment is anticipated to witness lucrative growth during the forecast period owing to increasing prevalence of chronic diseases, including cancer and diabetes, which require long-term treatment. Moreover, growing investments by governments for building cancer centers will further propel demand over the next eight years. For instance, Cancer Research Foundation Australia invested ¢â€š¹8 million for establishing a center that will provide advanced care & diagnosis services related to immunotherapy at one site within Royal Melbourne Hospital complex in Australia.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, advanced research infrastructure and high adoption rate of novel therapies. The U.S., in particular, is a lucrative market for immunotherapy as it has one of the largest populations suffering from cancer and other chronic diseases worldwide.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to untapped opportunities and rapidly improving healthcare infrastructure & expenditure in emerging countries such as China & India.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the TCR therapy market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This growing prevalence of cancer is expected to drive demand for TCR therapy products over the forecast period.
- Rising awareness about TCR therapy: There is a rising awareness about TCR therapy among patients and healthcare professionals due to its potential benefits over other treatment options available currently such as chemotherapy and radiation therapy. This is expected to boost adoption rates of TCR therapies over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
TCR Therapy Market Research Report
By Type
Transduction of Chimeric Antigen Receptor, Transduction of TCR α/B Heterodimer
By Application
Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes, Others
By Companies
Adaptimmune Therapeutics PLC, Immunocore, Medigene, Adaptive Biotechnologies, Lion TCR, TCR2 Therapeutics, Inc., RootPath, Kite Pharma, Guangzhou Xiangxue Pharmaceutical Co., Ltd, Eureka Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global TCR Therapy Market Report Segments:
The global TCR Therapy market is segmented on the basis of:
Types
Transduction of Chimeric Antigen Receptor, Transduction of TCR α/B Heterodimer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adaptimmune Therapeutics PLC
- Immunocore
- Medigene
- Adaptive Biotechnologies
- Lion TCR
- TCR2 Therapeutics, Inc.
- RootPath
- Kite Pharma
- Guangzhou Xiangxue Pharmaceutical Co., Ltd
- Eureka Therapeutics
Highlights of The TCR Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transduction of Chimeric Antigen Receptor
- Transduction of TCR α/B Heterodimer
- By Application:
- Hospitals
- Clinics & Ambulatory Centers
- Cancer Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the TCR Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TCR therapy is a type of cancer treatment that uses the immune system to fight cancer. TCR therapy works by training the bodyu2019s natural defenses to recognize and attack tumors.
Some of the major players in the tcr therapy market are Adaptimmune Therapeutics PLC, Immunocore, Medigene, Adaptive Biotechnologies, Lion TCR, TCR2 Therapeutics, Inc., RootPath, Kite Pharma, Guangzhou Xiangxue Pharmaceutical Co., Ltd, Eureka Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 TCR Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 TCR Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 TCR Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the TCR Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global TCR Therapy Market Size & Forecast, 2018-2028
4.5.1 TCR Therapy Market Size and Y-o-Y Growth
4.5.2 TCR Therapy Market Absolute $ Opportunity
Chapter 5 Global TCR Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 TCR Therapy Market Size Forecast by Type
5.2.1 Transduction of Chimeric Antigen Receptor
5.2.2 Transduction of TCR α/B Heterodimer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global TCR Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 TCR Therapy Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics & Ambulatory Centers
6.2.3 Cancer Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global TCR Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 TCR Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America TCR Therapy Analysis and Forecast
9.1 Introduction
9.2 North America TCR Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America TCR Therapy Market Size Forecast by Type
9.6.1 Transduction of Chimeric Antigen Receptor
9.6.2 Transduction of TCR α/B Heterodimer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America TCR Therapy Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics & Ambulatory Centers
9.10.3 Cancer Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe TCR Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe TCR Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe TCR Therapy Market Size Forecast by Type
10.6.1 Transduction of Chimeric Antigen Receptor
10.6.2 Transduction of TCR α/B Heterodimer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe TCR Therapy Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics & Ambulatory Centers
10.10.3 Cancer Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific TCR Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific TCR Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific TCR Therapy Market Size Forecast by Type
11.6.1 Transduction of Chimeric Antigen Receptor
11.6.2 Transduction of TCR α/B Heterodimer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific TCR Therapy Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics & Ambulatory Centers
11.10.3 Cancer Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America TCR Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America TCR Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America TCR Therapy Market Size Forecast by Type
12.6.1 Transduction of Chimeric Antigen Receptor
12.6.2 Transduction of TCR α/B Heterodimer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America TCR Therapy Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics & Ambulatory Centers
12.10.3 Cancer Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) TCR Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) TCR Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) TCR Therapy Market Size Forecast by Type
13.6.1 Transduction of Chimeric Antigen Receptor
13.6.2 Transduction of TCR α/B Heterodimer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) TCR Therapy Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics & Ambulatory Centers
13.10.3 Cancer Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 TCR Therapy Market: Competitive Dashboard
14.2 Global TCR Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adaptimmune Therapeutics PLC
14.3.2 Immunocore
14.3.3 Medigene
14.3.4 Adaptive Biotechnologies
14.3.5 Lion TCR
14.3.6 TCR2 Therapeutics, Inc.
14.3.7 RootPath
14.3.8 Kite Pharma
14.3.9 Guangzhou Xiangxue Pharmaceutical Co., Ltd
14.3.10 Eureka Therapeutics
